Anupam Rasayan Q1FY27 revenue up 35%, profit dips 11% YoY
Anupam Rasayan India Limited posted Q1FY27 consolidated revenue of ₹6,549.80 million, up 35% YoY, while net profit fell 11% to ₹386.39 million. EBITDA rose 30% to ₹1,620 million, but margins slipped to 24.8% from 25.6% due to rising employee and finance costs.
*this image is generated using AI for illustrative purposes only.
Anupam Rasayan India Limited reported significant top-line growth for the first quarter of FY27, with consolidated revenue from operations expanding by 35% year-on-year to ₹6,549.80 million. This compares to ₹4,858.27 million in the corresponding period of FY25. Despite the robust revenue expansion, consolidated net profit attributable to owners dipped 11% to ₹386.39 million, down from ₹426.50 million in Q4FY26 and lower than the ₹340.36 million recorded in Q1FY25.
Operating profitability showed mixed signals. Consolidated EBITDA rose 30% year-on-year to ₹1,620 million (₹1.62 billion), up from ₹1,240 million (₹1.24 billion) in Q1FY25. However, the EBITDA margin contracted to 24.8% from 25.6% in the previous year, indicating that cost pressures outpaced revenue growth. Standalone revenue also grew 4% year-on-year to ₹3,288.05 million, while standalone PAT increased 8% to ₹320.06 million.
Financial Performance Highlights
| Metric | Q1FY27 (₹m) | Q4FY26 (₹m) | Q1FY26 (₹m) | YoY Change |
|---|---|---|---|---|
| Consolidated Revenue | 6,549.80 | 6,357.83 | 4,858.27 | +35% |
| Consolidated PAT (Owners) | 386.39 | 426.50 | 340.36 | -11% |
| Consolidated EBITDA | 1,620.00 | N/A | 1,240.00 | +30% |
| Standalone Revenue | 3,288.05 | 3,705.79 | 3,156.94 | +4% |
| Standalone PAT | 320.06 | 423.84 | 296.94 | +8% |
On a standalone basis, basic earnings per share were reported at ₹2.81, compared to ₹2.70 in the corresponding quarter last year. Total comprehensive income for the group rose to ₹514.93 million from ₹476.39 million a year ago.
What the Numbers Show
A notable divergence exists between the company’s revenue growth and its profitability metrics. While consolidated revenue surged by over 35% year-on-year, employee benefit expenses more than tripled to ₹648.84 million from ₹203.31 million in Q1FY25. This sharp rise in personnel costs, alongside an increase in finance costs to ₹491.92 million from ₹356.65 million, contributed to the compression in net margins despite robust top-line expansion. The data suggests that operational scaling is currently accompanied by disproportionate increases in fixed cost structures, leading to a slight contraction in EBITDA margin from 25.6% to 24.8%.
Board Appointments and Governance
During its meeting on August 14, 2026, the Board of Directors approved the unaudited financial results for both standalone and consolidated entities. The board also appointed Mr. Ravi Desai as Chief Operating Officer, effective immediately, while he continues to serve as a Key Managerial Personnel.
The unaudited interim results were reviewed by Natvarlal Vepari & Co., Chartered Accountants, Surat, in accordance with Standard on Review Engagements (SRE) 2410. The consolidated results include subsidiaries such as Jainam Intermediates Private Limited and Tanfac Industries Limited, as well as associate Tangent Science Private Limited.
Historical Stock Returns for Anupam Rasayan
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.83% | +0.40% | -4.09% | -8.87% | +6.19% | +61.48% |
Will Anupam Rasayan implement specific cost-control measures to reverse the EBITDA margin contraction from 25.6% to 24.8% in the upcoming quarters?
How will the appointment of Mr. Ravi Desai as COO influence the company's operational efficiency and management of rising employee benefit expenses?
Is the 35% revenue growth driven by volume expansion or price increases, and how sustainable is this trajectory given current chemical sector demand trends?
17
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
